Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V9MV
|
||||
Former ID |
DIB016503
|
||||
Drug Name |
IDDBCP226234
|
||||
Synonyms |
Serine/threonine-protein kinase PIM-2 inhibitor (inflammation), Boehringer Ingelheim
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543564] | ||
Company |
Boehringer Ingelheim Corp
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(nc(cn1)c1cccc(c1)/C=C/C(=O)O)N[C@@H]1CC[C@H](CC1)N
|
||||
Target and Pathway | |||||
Target(s) | Serine/threonine-proteinkinase pim-2 | Target Info | Inhibitor | [543564] | |
KEGG Pathway | Acute myeloid leukemia | ||||
WikiPathways | Hematopoietic Stem Cell Differentiation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.